Position in GILD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$48,222,020
-$8,974,820 QoQ
Shares Held
346,000
-25.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. GILD ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
524,361 | $482,291,516 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,895,165 | $227,969,397 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,509,000 | $152,170,850 | |
| 4 | BIIB |
Biogen Inc.
|
704,196 | $129,100,252 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
346,000 | $48,222,020 | |
| 6 | JNJ |
Johnson & Johnson
|
182,381 | $44,581,211 | |
| 7 | ABBV |
AbbVie Inc.
|
145,134 | $31,565,193 | |
| 8 | AMGN |
Amgen Inc
|
53,892 | $18,961,900 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,222,020 | 346,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $57,196,840 | 466,000 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $48,784,500 | 439,500 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $45,268,331 | 408,301 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $16,471,350 | 147,000 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $14,502,090 | 157,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $16,038,592 | 191,300 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $13,756,305 | 200,500 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $13,844,250 | 189,000 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $13,557,023 | 167,350 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $13,601,610 | 181,500 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $9,409,938 | 122,096 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $9,516,659 | 114,700 | Shares | Sole | 2026-03-18 | |
| 2022-12-31 | $3,949,958 | 46,010 | Shares | Sole | 2026-03-18 | |
| 2022-09-30 | $3,405,288 | 55,200 | Shares | Sole | 2026-03-18 | |
| 2022-06-30 | $2,645,468 | 42,800 | Shares | Sole | 2026-03-18 | |
| 2022-03-31 | $1,070,100 | 18,000 | Shares | Sole | 2026-03-18 | |
| 2021-12-31 | $1,306,980 | 18,000 | Shares | Sole | 2026-03-18 | |
| 2021-09-30 | $2,497,556 | 35,756 | Shares | Sole | 2026-03-18 | |
| 2021-06-30 | $54,164,931 | 786,595 | Shares | Sole | 2026-03-18 | |
| 2021-03-31 | $50,837,634 | 786,595 | Shares | Sole | 2026-03-18 | |
| 2020-12-31 | $45,827,024 | 786,595 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $49,704,938 | 786,595 | Shares | Sole | 2026-03-20 | |
| 2020-03-31 | $53,974,626 | 721,972 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||